-
Nov 15, 2023
-
Nov 15, 2023
-
Nov 15, 2023
-
Eremid® Genomic Services, LLC ("Eremid"), a CLIA-certified leading-edge genomics CRO, has announced a strategic partnership with Semaphore Solutions, a leader in informatics services and SaaS solutions for the life sciences industry. Eremid will implement Semaphore’s Labbit LIMS across its research, clinical, and training labs, a move that will help take its end-to-end clinical genomics services to the next level and support the development of cutting-edge molecular diagnostics.
Nov 14, 2023
-
• Investment to accelerate development of a novel class of targeted high-potency bacteriocins against specific antimicrobial-resistant pathogens
• Spin-out from the Universities of Glasgow and Oxford
• Funding led by Boehringer Ingelheim Venture Fund and Scottish Enterprise
• Company to establish operations and expand team
Nov 13, 2023
-
Today, Oxford Nanopore and Day Zero Diagnostics announced a collaboration to develop a new class of diagnostics for bloodstream infections, a leading cause of sepsis.
According to the WHO,11 million sepsis-related deaths occur every year—early and effective intervention is key, but current diagnostics require a culture, taking days to get results.
Built for use in clinical settings, such as hospitals, the new solution leverages each company’s unique capabilities and will provide same-day identification and genomic-based antibiotic susceptibility profiling without the need for blood culture—so that patients can be prescribed targeted, life-saving treatments sooner. The companies plan to pursue regulatory approvals, including with the FDA, in the future.
Nov 13, 2023
-
Biopharma PEG introduces monodispersed PEGs, including mPEG36-NH2,NH2-PEG24-COOH, OH-PEG9-OH, mPEG8-SPA , for ADC development at diverse scales. R&D Director highlights their role in modulating ADC properties.
Nov 12, 2023
-
Huateng Pharma introduces advanced anti-diabetes intermediates, such as Canagliflozin, Dapagliflozin, Empagliflozin, and Semaglutide, representing a major step in diabetes treatment. These high-purity compounds have the potential to revolutionize drug development. Huateng Pharma also offers CDMO services to promote collaboration in the pharmaceutical industry.
Nov 12, 2023
-
Fapon is thrilled to announce the grand opening of its US-based Research and Development (R&D) Center, strategically located in Lexington, Massachusetts. This Center represents Fapon’s unwavering commitment to advancing healthcare technologies and will further integrate the company into the local biotechnology ecosystem to accelerate growth.
Nov 8, 2023
-
Medix Biochemica has acquired 100 percent of the shares of ViroStat.
Nov 9, 2023
-
Nov 8, 2023
-
In a peer-reviewed study published today, a team of scientists from French-American techbio Owkin and pathology labs in France present a blind validation of MSIntuit™ CRC, a first-in-class AI-driven digital pathology diagnostic
Nov 5, 2023
-
SPT Labtech announces new developments to its firefly® all-in-one genomics liquid handling platform, specifically targeted to address the bottlenecks of NGS library preparation in Laboratory Developed Tests.
Nov 2, 2023
-
Centralized hub for advanced testing of nucleic acids to simplify mRNA drug substance testing, accelerating critical therapeutic development
Nov 1, 2023
-
Oct 31, 2023
-
Oct 31, 2023
-
JPA Health Unveils Connectability Score to Measure Relationships Between Key Audiences
Oct 31, 2023
-
STEMart has announced the launch of its Disinfection Efficacy Studies Services in various standards to ensure the safety of medical devices.
Oct 31, 2023
-
Creative Diagnostics has launched a range of antibodies, antigens and kits against CLDN6 to support researchers.
Oct 31, 2023
-
CD BioSciences has announced the launch of its 3D Image Analysis Services for researchers.
Oct 31, 2023